	Does rimegepant prevent migraine attacks in people who have not found other treatments taken by mouth (orally) to work well? A plain language summary of clinical study findings. Pain Manag Pozo-Rosich P, Gien López JA, Lisewski P, Aslan AN, Seehra H, Thiry A, Abraham L, Ramirez LM, Fountaine R, Fullerton T. PMID: 42047365 [PubMed - as supplied by publisher]
	Impact of bariatric surgery on headache frequency and severity and quality of life in patients with migraine: a prospective study. BMJ Neurol Open Ali M, Abu Galal EM, Magdy R, Hussein M, Essam AM, Khalil DM, Farrag MA. PMID: 42046566 [PubMed]
	The mechanism of different microglial receptors mediating central inflammation in chronic migraine: a meta-analysis. J Headache Pain Lin X, Yu W, Lou J, Cao Z, Song W. PMID: 42045826 [PubMed - as supplied by publisher]
	Botulinum Toxin for Chronic Migraine: Beyond Headache Reduction and Toward Possible Cognitive Benefits. Toxins (Basel) Silvestrini M, Viticchi G, Salvemini S, De Vanna G, Bartolini M, Luzzi S. PMID: 42043017 [PubMed - indexed for MEDLINE]
	Comparing the Efficacy and Safety of Anti-CGRP Monoclonal Antibodies Versus Topiramate for Migraine Prophylaxis: Six-Month, Real-World, Intention-to-Treat Retrospective Evidence from the GRASP Study Group. Neurol Int Vikelis M, Rikos D, Argyriou AA, Soldatos P, Tsironis C, Giakoumakis E, Xiromerisiou G, Chondrogianni M, Foska A, Koutsokera M, Notas K, Mavraki E, Dermitzakis EV, Greek Research Alliance for the Study of Headache and Pain (GRASP) Study Group. PMID: 42042754 [PubMed]
	Senkyunolides: a promising natural compounds for the treatment of migraine headaches. Front Nutr Long Y, Li D, Jian X, Yang Z, Leng T, Wang X, Zhang W, Ge X, Li N, Yin Y, Li X. PMID: 42039900 [PubMed]
	Algometric assessment of sensitization and habituation as predictive markers for OnabotulinumtoxinA response in chronic migraine. Pain Med Gomez-Pilar J, Vaquerizo-Villar F, García-Azorín D, Sierra-Mencía Á, Guerrero-Peral ÁL, Hornero R. PMID: 42036814 [PubMed - as supplied by publisher]
	Physical activity in migraine: Identifying an engagement threshold and patient clusters in a population-based cohort. Cephalalgia Peles I, Sharvit S, Novack V, Ifergane G. PMID: 42033407 [PubMed - indexed for MEDLINE]
	The Relevance of Crystal Clear and Unclear Days to Evaluate Residual Interictal Burden in Patients With Migraine Treated With CGRP Monoclonal Antibodies. Eur J Neurol Silvestro M, Orologio I, Ornello R, Trojsi F, Tessitore A, Sacco S, Russo A. PMID: 42029417 [PubMed - indexed for MEDLINE]
	Stress and fasting for inducing migraine attacks: A randomized 2â€‰Ã—â€‰2 factorial crossover trial. Headache Houle TT, Sexton K, Lebowitz A, Chtay I, Patel T, Leffert L, Turner DP. PMID: 42026859 [PubMed - as supplied by publisher]
	Migraine and the Risk of Dementia in the General Population. Alzheimers Dement Acarsoy C, Bos D, Mooldijk SS, Ikram MA, Ikram MK. PMID: 42026653 [PubMed - indexed for MEDLINE]
	Serum otolin-1 levels in vestibular migraine and MÃ©niÃ¨re's disease: a comparative clinical study. Eur Arch Otorhinolaryngol Elden H, Yilmaz MS, Altindis M, Akca G, Cihan A, Vural G. PMID: 42026293 [PubMed - as supplied by publisher]
	The Efficacy and Safety of Rimegepant Every Other Day as Preventive Treatment for Migraine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Curr Pain Headache Rep Attar A, Alqsair A, Halabi M, Barwais K, Alzaid A, Alshaikhi R, Alamri L, Aljadani H, Alsharif J, Zagzoog N, Aladdin Y. PMID: 42024209 [PubMed - in process]
	Visually-induced hemodynamic response and white matter hyperintensities in middle-aged women with ischemic stroke or migraine with aura. Cephalalgia van der Weerd N, Ali M, van Harten TW, Ma AM, Holswilder G, Wilms AE, van Zwet EW, Kruit MC, van den Maagdenberg AMJM, Terwindt GM, van Osch MJP, van Os HJA, Wermer MJH. PMID: 42024133 [PubMed - indexed for MEDLINE]
	Potential Roles of G Protein-Coupled Receptor 30 (GPR30) in Migraine Pathophysiology. J Pain Res Yao Y, Gong Y, Cao K. PMID: 42022495 [PubMed]
	The effects of Mixodin supplementation on migraine headache characteristics, oxidative stress and inflammatory biomarkers in patients with migraine: a double-blind, placebo-controlled, randomized trial. Nutr J Askari MA, Golpour-Hamedani S, Khorvash F, Yegdaneh A, Vajdi M. PMID: 42021338 [PubMed - as supplied by publisher]
	Correction: Alterations of static and dynamic functional connectivity of the nucleus accumbens subregions may be associated with chronic process of migraine: a resting-state fMRI study. J Headache Pain Liu G, Lin C, Qiu D, Li X, Guo Z, Li Y, Mei Y, Zhang M, Wang J, Liu X, Ge Z, Xiong Z, Sui B, Wang Y. PMID: 42021153 [PubMed - in process]
	Effectiveness of Galcanezumab and Traditional Oral Migraine Preventive Medications: Interim 3-Month Japan Subgroup Findings from the TRIUMPH Study. Adv Ther Takeshima T, Matsumori Y, Danno D, Takizawa T, Ueda K, Cai Z, Hashimoto C, Katagiri H. PMID: 42018233 [PubMed - as supplied by publisher]
	Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3-Month results from the TRIUMPH study. Headache Joshi S, Tassorelli C, Matharu M, Alsaadi T, Vallarino C, Viktrup L, Vincent M, Robinson RL. PMID: 42017407 [PubMed - as supplied by publisher]
	Discriminating migraine aura from transient ischemic attack using MRI-based oxygen metabolism mapping: A preliminary study. Headache Pernot P, Bani-Sadr A, Ong E, Cho TH, Berthezène Y, Demarquay G, Hermier M. PMID: 42017276 [PubMed - as supplied by publisher]

Articles 1 - 20 / 17219

Page 1 of 861



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy